Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KB 130015

Known as: 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran, KB-130015, KB130015 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Human ether à go-go related gene (hERG1) potassium channels underlie the repolarizing I(Kr) current in the heart. Since they are… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015) has been developed to retain the antiarrhythmic properties of… Expand
2006
2006
KB130015 [KB; 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran] is a novel amiodarone derivative designed to retain the… Expand
2005
2005
BACKGROUND AND PURPOSE Vagus-induced atrial fibrillation is of particular clinical interest. The muscarinic potassium current I(K… Expand
2005
2005
ZusammenfassungHintergrund und Ziel:Bei Erwachsenen ist das vagale Vorhofflimmern von besonderer klinischer Relevanz… Expand
2004
2004
2-Methyl-3- (3,5-diiodo-4-carboxymethoxybenzyl) benzofuran (KB130015; KB), a novel compound derived from amiodarone, has been… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2003
2003
We have studied the acute cardiac electrophysiological effects of KB130015 (KB), a drug structurally related to amiodarone… Expand
2003
2003
2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015 or KB) is a new drug, structurally related to amiodarone and… Expand
  • figure 1
  • figure 2
  • figure 5
  • figure 6
  • figure 7
Review
2003
Review
2003
KB130015 (KB015), a new drug structurally related to amiodarone, has been proposed to have antiarrhythmic properties. In contrast… Expand